下一代免疫肿瘤疗法有望重塑相关治疗格局?花旗上调这些公司目标价

制药网
28 Jul

【制药网 市场分析】在医疗领域,肿瘤治疗一直是备受关注的焦点。近年来,下一代免疫肿瘤疗法崭露头角,有望重塑相关治疗格局。花旗的研究报告指出,下一代免疫疗法药物的总市场规模(TAM)可能超过620亿美元,这一庞大的市场潜力预示着该领域将迎来重大变革。传统的肿瘤治疗方法,如手术、化疗和放疗,在治疗过程中往往存在诸多局限性。手术治疗对于一些晚期或转移性肿瘤可能无法完全清除病灶;化疗和放疗则在杀死肿瘤细胞...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10